Diagnostic and Interventional Radiology
Interventional Radiology - Original Article
Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy

Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy

1.

-Department of Radiology and Nuclear Medicine, Otto-von-Guericke University School of Medicine, Magdeburg, Germany

2.

Department of Radiology and Nuclear Medicine, Otto-von-Guericke University School of Medicine, Magdeburg, Germany; Department of Radiology, Gdansk University School of Medicine, Gdansk, Poland

Diagn Interv Radiol 2019; 25: 360-367
DOI: 10.5152/dir.2019.18390
Read: 57 Downloads: 36 Published: 07 October 2019

PURPOSE

We aimed to evaluate the safety and effectiveness of image-guided high-dose rate interstitial brachytherapy (iBT) for the treatment of patients with hepatic, lymphatic, and pancreatic metastases originating from gastric cancer, an entity rarely surgically treatable with curative intent.

METHODS

Twelve patients with a cumulative number of 36 metastases (29 liver, 2 pancreatic, 5 lymph node) from histologically proven gastric adenocarcinoma received iBT between 2010 and 2016 and were retrospectively analyzed. Every patient underwent palliative chemotherapy prior to iBT. The iBT procedure employs a temporarily, intratumorally placed iridium-192 source in a single fraction with the goal of tumor cell eradication. Effectiveness was assessed clinically and by radiologic imaging every three months.

RESULTS

Local tumor control was achieved in 32 of all treated metastases (89%). Four lesions showed a local recurrence after 7 months. Lesion sizes varied from 9 to 102 mm with a median of 20 mm. The median progression-free survival was 6.6 months (range, 1.8–46.8 months). The median overall survival was 11.4 months (range, 5–47 months). One patient suffered a major complication following iBT, hepatic hematoma and abscess (Common Terminology Criteria for Adverse Events grade 3), successfully dealt with by transcutaneous drainage.

CONCLUSION

iBT is an overall safe procedure, which facilitates high rates of local tumor control in treatment of metastatic gastric adenocarcinoma. Compared with surgical metastasectomy, similar overall survival rates could be achieved in our patient collective after iBT application.

 

You may cite this article as: Omari J, Drewes R, Othmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy. Diagn Interv Radiol 2019; 25:360–367.

Files
EISSN 1305-3612
3